Upgrade to SI Premium - Free Trial

Form EFFECT Karyopharm Therapeutics

May 15, 2026 6:35 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 14, 2026 4:30 P.M.
Form: S-3
CIK: 0001503802
Company Name: Karyopharm Therapeutics Inc.
File Number: 333-295535

Categories

SEC Filings